Summary
Stroke is the second leading cause of death with 16 million strokes occurring worldwide each year. The randomized Interventional Management of Stroke III Trial [IMS III] study was designed to test whether endovascular therapy following IV tPA was more efficacious than IV tissue plasminogen activator (tPA) alone [Broderick JP et al. N Engl J Med 2013].
- Interventional Techniques & Devices
- Neurology
- Interventional Techniques & Devices
- Exclusive Article - For home page
- © 2013 MD Conference Express®
Tools
IMS III: Results and Perspective
Permalink:
